Mrv1909 05201914432D 19 21 0 0 1 0 999 V2000 0.2078 7.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6127 7.4102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.9482 6.6565 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.5357 5.9420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0878 5.3289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8414 5.6645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.7552 6.4850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5559 5.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5559 4.4270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2704 4.0145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2704 3.1895 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.5559 2.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5559 1.9520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9684 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9849 4.4270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.9849 5.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6993 5.6645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.2704 5.6645 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 3 2 1 6 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 3 7 1 0 0 0 0 6 8 1 0 0 0 0 8 9 2 0 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 13 15 1 0 0 0 0 10 16 2 0 0 0 0 16 17 1 0 0 0 0 17 18 1 0 0 0 0 17 19 2 0 0 0 0 8 19 1 0 0 0 0 M END > DB15027 > drugbank > CN[C@@H]1CCN(C1)C1=CC(NCC2CC2)=NC(N)=N1 > InChI=1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1 > ISBHYKVAFKTATD-SNVBAGLBSA-N > C13H22N6 > 262.361 > 262.190594732 > 6 > 41 > 30.29643319708481 > 1 > 3 > 0 > 1 > N4-(cyclopropylmethyl)-6-[(3R)-3-(methylamino)pyrrolidin-1-yl]pyrimidine-2,4-diamine > 1.64 > 1.0337082939999993 > -3.25 > 0 > 3 > 2 > 17.053786026857814 > 9.59488268478004 > 79.1 > 79.8511 > 5 > 1 > 1.47e-01 g/l > (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one > 0 > DB15027 > investigational > Adriforant > Adriforant; PF-03893787 $$$$